BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 3283480)

  • 1. Screening and evaluation of anticancer agents.
    Zee-Cheng RK; Cheng CC
    Methods Find Exp Clin Pharmacol; 1988 Feb; 10(2):67-101. PubMed ID: 3283480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticancer Drug Development: The Way Forward.
    Connors T
    Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Application to chemosensitivity tests of the human tumor-nude mouse system and subrenal capsule assay system].
    Fujita M; Fujita F; Shimozuma K; Sakamoto Y; Kusuyama T; Usugane M; Origasa H; Taguchi T
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1227-34. PubMed ID: 3729446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Predictability of preclinical evaluation of anticancer drugs by human gastrointestinal cancer--nude mouse panel].
    Fujita M; Fujita F; Sakamoto Y; Sugimoto T; Shimozuma K; Taguchi T
    Gan To Kagaku Ryoho; 1991 Jul; 18(9):1429-37. PubMed ID: 1854213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer Drug Development: New Targets for Cancer Treatment.
    Curt GA
    Oncologist; 1996; 1(3):II-III. PubMed ID: 10387987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of a human tumor colony-forming assay to new drug screening.
    Shoemaker RH; Wolpert-DeFilippes MK; Kern DH; Lieber MM; Makuch RW; Melnick NR; Miller WT; Salmon SE; Simon RM; Venditti JM
    Cancer Res; 1985 May; 45(5):2145-53. PubMed ID: 3986767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Closing Remarks.
    Reed E
    Oncologist; 1996; 1(4):276-277. PubMed ID: 10388002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Application of nude mouse-human cancer xenograft system for sensitivity test of anticancer drugs].
    Fujita M; Taguchi T
    Gan To Kagaku Ryoho; 1982 Apr; 9(4):606-15. PubMed ID: 7184418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The preclinical new drug research program of the National Cancer Institute.
    Driscoll JS
    Cancer Treat Rep; 1984 Jan; 68(1):63-76. PubMed ID: 6692438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of nude mouse xenografts as preclinical drug screens: in vivo activity of established chemotherapeutic agents against melanoma and ovarian carcinoma xenografts.
    Taetle R; Rosen F; Abramson I; Venditti J; Howell S
    Cancer Treat Rep; 1987 Mar; 71(3):297-304. PubMed ID: 3815395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a panel of 15 human ovarian cancer xenografts for drug screening and determination of the role of the glutathione detoxification system.
    Kolfschoten GM; Pinedo HM; Scheffer PG; Schlüper HM; Erkelens CA; Boven E
    Gynecol Oncol; 2000 Mar; 76(3):362-8. PubMed ID: 10684711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Challenge of Developing New Therapies for Childhood Cancers.
    Balis FM
    Oncologist; 1997; 2(1):I-II. PubMed ID: 10388032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human tumor xenografts in the nude mouse and their value as test models in anticancer drug development (review).
    Winograd B; Boven E; Lobbezoo MW; Pinedo HM
    In Vivo; 1987; 1(1):1-13. PubMed ID: 2979758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis of metastatic disease: implications for current therapy and for the development of new therapeutic strategies.
    Poste G
    Cancer Treat Rep; 1986 Jan; 70(1):183-99. PubMed ID: 3510734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical studies on a new screening assay for anticancer agents using nude mice and isotopic evaluation.
    Noso Y; Niimi K; Nishiyama M; Hirabayashi N; Toge T; Niimoto M; Hattori T
    Cancer Res; 1987 Dec; 47(23):6418-22. PubMed ID: 3677085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Of mice and men: values and liabilities of the athymic nude mouse model in anticancer drug development.
    Kelland LR
    Eur J Cancer; 2004 Apr; 40(6):827-36. PubMed ID: 15120038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 50 years of preclinical anticancer drug screening: empirical to target-driven approaches.
    Suggitt M; Bibby MC
    Clin Cancer Res; 2005 Feb; 11(3):971-81. PubMed ID: 15709162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chemosensitivity test for human gliomas].
    Nakamura O; Matsutani M; Sasaki T; Tanaka M; Endo Y; Takakura K
    No To Shinkei; 1988 Oct; 40(10):913-7. PubMed ID: 3196494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug research: from the idea to the product.
    Kuhlmann J
    Int J Clin Pharmacol Ther; 1997 Dec; 35(12):541-52. PubMed ID: 9455711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.